<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pediatricjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Архив педиатрии и детской хирургии</journal-title><trans-title-group xml:lang="en"><trans-title>Archives of Pediatrics and Pediatric Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-4664</issn><issn pub-type="epub">3033-6783</issn><publisher><publisher-name>НИКИ детства Минздрава Московской области</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/2949-4664-apps-2-1-113-120</article-id><article-id custom-type="elpub" pub-id-type="custom">pediatricjournal-64</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МИКРОБИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MICROBIOLOGY</subject></subj-group></article-categories><title-group><article-title>Инфекции, ассоциированные с бактериями рода Elizabethkingia, у детей с муковисцидозом и оперированными по причине врожденных пороков сердца: микробиологические особенности и клиническое значение</article-title><trans-title-group xml:lang="en"><trans-title>Infections associated with bacteria of the genus Elizabethkingia in children with cystic fibrosis and operated on due to congenital heart defects: microbiological features and clinical significance</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7750-9468</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кондратенко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kondratenko</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">o.v.kondratenko@samsmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5905-1895</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лямин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lyamin</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6395-0407</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кондратьева</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kondratyeva</surname><given-names>E. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-6729-1365</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бочкарева</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bochkareva</surname><given-names>P. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Самарский государственный медицинский университет» Министерства здравоохранения Российской Федерации<country>Россия</country></aff><aff xml:lang="en">Samara State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ «Медико-генетический научный центр имени академика Н. П. Бочкова»; ГБУЗ Московской области «Научно-исследовательский клинический институт детства Министерства здравоохранения Московской области»<country>Россия</country></aff><aff xml:lang="en">Academician N. P. Bochkov Medical Genetic Research Center”; Research Clinical Institute of Childhood<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>26</day><month>03</month><year>2024</year></pub-date><volume>2</volume><issue>1</issue><fpage>113</fpage><lpage>120</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кондратенко О.В., Лямин А.В., Кондратьева Е.И., Бочкарева П.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Кондратенко О.В., Лямин А.В., Кондратьева Е.И., Бочкарева П.В.</copyright-holder><copyright-holder xml:lang="en">Kondratenko O.V., Lyamin A.V., Kondratyeva E.I., Bochkareva P.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nikid.ru/jour/article/view/64">https://journal.nikid.ru/jour/article/view/64</self-uri><abstract><p>Бактерии рода Elizabethkingia являются грамотрицательными палочковидными бактериями, встречающимися повсеместно. Основным резервуаром для представителей данного рода являются вода и почва. Несмотря на это, появляется все больше клинических данных, свидетельствующих о роли данных представителей в развитии внутрибольничных и внебольничных инфекций, чаще всего сепсиса и менингита. Группой риска являются новорожденные, дети, пожилые люди, пациенты с муковисцидозом (МВ) и люди с иммунодефицитами. Инфекции, ассоциированные с Elizabethkingia spp., как правило, связаны с высоким уровнем смертности (18,2-41%) и чаще всего наблюдаются у новорожденных и пациентов с ослабленным иммунитетом. Представители рода Elizabethkingia имеют природную устойчивость ко многим антибиотикам, традиционно назначаемым при инфицировании грамотрицательными бактериями. Своевременная диагностика и раннее назначение соответствующей комбинированной терапии имеют решающее значение в лечении таких инфекций. В период 2018-2023 гг. из биологического материала, полученного от детей с МВ и 8 новорожденных детей кардиологического профиля, прооперированных по жизненным показаниям ввиду наличия врожденных пороков развития сердца, наблюдалось выделение бактерий рода Elizabethkingia. Бактерии рода Elizabethkingia были выделены от 15 пациентов с МВ, из них у пяти пациентов отмечены повторные высевы, за указанный период идентифицировано 28 штаммов. Из них в 2018 и 2020 по 2 штамма, 2019-13, 2021-6 и 2022-5 штаммов. У обследованных новорожденных выделение данных бактерий обнаруживалось за 2021 год от 4 пациентов, за 2022 - у 3 пациентов и у одного пациента в 2023 году, соответственно. Бактерии рода Elizabethkingia являются относительно новыми и малоизученными возбудителями внутрибольничных инфекций, ассоциированных с высоким риском осложнений и смертности у недоношенных новорожденных и иммунокомпрометированных больных, что требует повышенного внимания, как со стороны медицинских микробиологов, так и со стороны клиницистов различного профиля.</p></abstract><trans-abstract xml:lang="en"><p>Bacteria of the genus Elizabethkingia are gram-negative rod-shaped bacteria found throughout the world. The main reservoir for representatives of this genus is water and soil. Despite this, more and more clinical data are emerging indicating the role of these representatives in the development of nosocomial and community-acquired infections, most often sepsis and meningitis. Risk groups include newborns, children, the elderly, patients with cystic fibrosis (CF) and people with immunodeficiencies. Infections associated with Elizabethkingia spp. are generally associated with high mortality rates (18.2-41%) and are most often observed in neonates and immunocompromised patients. Members of the genus Elizabethkingia are naturally resistant to many of the antibiotics traditionally prescribed for infections with gram-negative bacteria. Timely diagnosis and early initiation of appropriate combination therapy are critical in the treatment of such infections. During the period 2018-2023. Isolation of bacteria of the genus Elizabethkingia was observed from biological material obtained from children with CF and 8 newborn children with a cardiac profile who underwent life-saving surgery due to the presence of congenital heart defects. Bacteria of the genus Elizabethkingia were isolated from 15 patients with CF, of which repeat cultures were noted in five patients; 28 strains were identified during the specified period. Of these, in 2018 and 2020 there were 2 strains each, 2019-13, 2021-6 and 2022-5 strains. In the examined newborns, isolation of these bacteria was detected in 4 patients in 2021, in 3 patients in 2022, and in one patient in 2023, respectively. Bacteria of the genus Elizabethkingia are relatively new and poorly studied pathogens of nosocomial infections associated with a high risk of complications and mortality in premature newborns and immunocompromised patients, which requires increased attention from both medical microbiologists and clinicians of various profiles.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>новорожденные</kwd><kwd>муковисцидоз</kwd><kwd>Elizabethkingia</kwd><kwd>хирургические инфекции</kwd><kwd>сепсис</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>newborns</kwd><kwd>cystic fibrosis</kwd><kwd>Elizabethkingia</kwd><kwd>surgical infections</kwd><kwd>sepsis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Aldoghaim F. S., Kaabia N., Alyami A. M. et.al. Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteraemia: a series of 12 cases at Prince Sultan Military Medical City KSA. New Microbes New Infect. 2019; Oct; 25(32):100617. doi: 10.1016/j.nmni.2019.100617.</mixed-citation><mixed-citation xml:lang="en">Aldoghaim F. S., Kaabia N., Alyami A. M. et.al. Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteraemia: a series of 12 cases at Prince Sultan Military Medical City KSA. New Microbes New Infect. 2019; Oct; 25(32):100617. doi: 10.1016/j.nmni.2019.100617.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kanashenko M. E., Kartsev N. N., Mitsevich I. P. et al. Elizabethkingia meningoseptica as a significant clinical pathogene. Bacteriology. 2019; 4(1): 58-63. (In Russ.). doi: 10.20953/2500-1027-2019-1-58-63.@@ Канашенко М. Е., Карцев Н. Н., Мицевич И. П. и др. Elizabethkingia meningoseptica как значимый клинический патоген. Бактериология. 2019; 4(1): 58-63. doi: 10.20953/2500-1027-2019-1-58-63.</mixed-citation><mixed-citation xml:lang="en">Kanashenko M. E., Kartsev N. N., Mitsevich I. P. et al. Elizabethkingia meningoseptica as a significant clinical pathogene. Bacteriology. 2019; 4(1): 58-63. (In Russ.). doi: 10.20953/2500-1027-2019-1-58-63.@@ Канашенко М. Е., Карцев Н. Н., Мицевич И. П. и др. Elizabethkingia meningoseptica как значимый клинический патоген. Бактериология. 2019; 4(1): 58-63. doi: 10.20953/2500-1027-2019-1-58-63.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Waleed M. S., Amba V., Varughese A. A., Pathalapati R. Elizabethkingia meningoseptica Bacteremia and Meningitis: A Case Report. Cureus. 2021; Nov;13(11): e19275. doi: 10.7759/cureus.19275.</mixed-citation><mixed-citation xml:lang="en">Waleed M. S., Amba V., Varughese A. A., Pathalapati R. Elizabethkingia meningoseptica Bacteremia and Meningitis: A Case Report. Cureus. 2021; Nov;13(11): e19275. doi: 10.7759/cureus.19275.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu M. S., Liao C. H., Huang Y. T. et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011; Oct;30(10):1271-8. doi: 10.1007/s10096-011-1223-0.</mixed-citation><mixed-citation xml:lang="en">Hsu M. S., Liao C. H., Huang Y. T. et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011; Oct;30(10):1271-8. doi: 10.1007/s10096-011-1223-0.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Adachi A., Mori T., Simizu T. et al. Chryseobacterium meningosepticum septicemia in a recipient of allogeneic cord blood transplantation. Scand J Infect Dis. 2004; 36(6-7):539-40. doi: 10.1080/ 00365540410020587.</mixed-citation><mixed-citation xml:lang="en">Adachi A., Mori T., Simizu T. et al. Chryseobacterium meningosepticum septicemia in a recipient of allogeneic cord blood transplantation. Scand J Infect Dis. 2004; 36(6-7):539-40. doi: 10.1080/ 00365540410020587.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kirby J. T., Sader H. S., Walsh T. R., Jones R. N. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: Report from the SENTRY antimicrobial surveillance program (1997-2001). J Clin Microbiol. 2004; Jan; 42(1):445-8. doi: 10.1128/jcm.42.1.445-448.2004.</mixed-citation><mixed-citation xml:lang="en">Kirby J. T., Sader H. S., Walsh T. R., Jones R. N. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: Report from the SENTRY antimicrobial surveillance program (1997-2001). J Clin Microbiol. 2004; Jan; 42(1):445-8. doi: 10.1128/jcm.42.1.445-448.2004.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Güngör S., Ozen M., Akinci A., Durmaz R. A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol. 2003; Aug; 24(8):613-7. doi: 10.1086/502261.</mixed-citation><mixed-citation xml:lang="en">Güngör S., Ozen M., Akinci A., Durmaz R. A Chryseobacterium meningosepticum outbreak in a neonatal ward. Infect Control Hosp Epidemiol. 2003; Aug; 24(8):613-7. doi: 10.1086/502261.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rossolini G. M., Franceschini N., Riccio M. L. et al. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J. 1998; May; 15(332):145-52. doi: 10.1042/bj3320145.</mixed-citation><mixed-citation xml:lang="en">Rossolini G. M., Franceschini N., Riccio M. L. et al. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J. 1998; May; 15(332):145-52. doi: 10.1042/bj3320145.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ceyhan M., Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) infections in Children.Int J Pediatr. 2011:215237. doi: 10.1155/2011/215237.</mixed-citation><mixed-citation xml:lang="en">Ceyhan M., Celik M. Elizabethkingia meningosepticum (Chryseobacterium meningosepticum) infections in Children.Int J Pediatr. 2011:215237. doi: 10.1155/2011/215237.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bellais S., Poire L., Naas T. et al. Genetic biochemical analysis and distribution of the Ambler class A-lactamase CME-2, responsible for extended spectrum cephalosporin resistance in Elizabethkingae (Flavobacterium) meningosepticum. Antimicrob Agents Chemother. 2000; Jan; 44(1):1-9. doi: 10.1128/AAC.44.1.1-9.2000.</mixed-citation><mixed-citation xml:lang="en">Bellais S., Poire L., Naas T. et al. Genetic biochemical analysis and distribution of the Ambler class A-lactamase CME-2, responsible for extended spectrum cephalosporin resistance in Elizabethkingae (Flavobacterium) meningosepticum. Antimicrob Agents Chemother. 2000; Jan; 44(1):1-9. doi: 10.1128/AAC.44.1.1-9.2000.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G. X., Zhang R. H., Zhou W. Heterogeneity of metallo-β-lactamases in clinical isolates of Elizabethkingae meningosepticum from Hangzhou China. J Antimicrob Chemother. 2006; Apr; 57(4):750-2. doi: 10.1093/jac/dkl019.</mixed-citation><mixed-citation xml:lang="en">Chen G. X., Zhang R. H., Zhou W. Heterogeneity of metallo-β-lactamases in clinical isolates of Elizabethkingae meningosepticum from Hangzhou China. J Antimicrob Chemother. 2006; Apr; 57(4):750-2. doi: 10.1093/jac/dkl019.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">González L. J., Vila A. J. Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaB. Antimicrob Agents Chemother. 2012; Apr; 56(4):1686-92. doi: 10.1128/AAC.05835-11.</mixed-citation><mixed-citation xml:lang="en">González L. J., Vila A. J. Carbapenem Resistance in Elizabethkingia meningoseptica Is Mediated by Metallo-β-Lactamase BlaB. Antimicrob Agents Chemother. 2012; Apr; 56(4):1686-92. doi: 10.1128/AAC.05835-11.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lau S. K., Chow W. N., Foo C. H. et al. Elizabethkingia anopheles bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016; May; 17(6):26045. doi: 10.1038/srep26045.</mixed-citation><mixed-citation xml:lang="en">Lau S. K., Chow W. N., Foo C. H. et al. Elizabethkingia anopheles bacteremia is associated with clinically significant infections and high mortality. Sci Rep. 2016; May; 17(6):26045. doi: 10.1038/srep26045.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K. K., Kim M. K., Lim J. H. et al. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov.Int J Syst Evol Microbiol. 2005; May; 55(Pt. 3):1287-93. doi: 10.1099/ ijs.0.63541-0.</mixed-citation><mixed-citation xml:lang="en">Kim K. K., Kim M. K., Lim J. H. et al. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov.Int J Syst Evol Microbiol. 2005; May; 55(Pt. 3):1287-93. doi: 10.1099/ ijs.0.63541-0.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chan J. C., Chong C. Y., Thoon K. C. et al. Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone. J Med Microbiol. 2019; Aug; 68(8):1167-1172. doi: 10.1099/jmm.0.001021.</mixed-citation><mixed-citation xml:lang="en">Chan J. C., Chong C. Y., Thoon K. C. et al. Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin/tazobactam and trimethoprim/sulfamethoxazole or fluoroquinolone. J Med Microbiol. 2019; Aug; 68(8):1167-1172. doi: 10.1099/jmm.0.001021.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">de Carvalho Filho É. B., Marson F. A.L., Levy C. E. Challenges in the identification of Chryseobacterium indologenes and Elizabethkingia meningoseptica in cases of nosocomial infections and patients with cystic fibrosis. New Microbes New Infect. 2017; Sep; 13(20):27-33. doi: 10.1016/j.nmni.2017.09.002.</mixed-citation><mixed-citation xml:lang="en">de Carvalho Filho É. B., Marson F. A.L., Levy C. E. Challenges in the identification of Chryseobacterium indologenes and Elizabethkingia meningoseptica in cases of nosocomial infections and patients with cystic fibrosis. New Microbes New Infect. 2017; Sep; 13(20):27-33. doi: 10.1016/j.nmni.2017.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Frost F., Nazareth D. Case Report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis. F1000Res. 2018; Apr; 10(7):440. doi: 10.12688/f1000research.14441.2.</mixed-citation><mixed-citation xml:lang="en">Frost F., Nazareth D. Case Report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis. F1000Res. 2018; Apr; 10(7):440. doi: 10.12688/f1000research.14441.2.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zajmi A., Teo J., Yeo C. C. Epidemiology and Characteristics of Elizabethkingia spp. Infections in Southeast Asia. Microorganisms. 2022; Apr; 10(5):882. doi: 10.3390/microorganisms10050882.</mixed-citation><mixed-citation xml:lang="en">Zajmi A., Teo J., Yeo C. C. Epidemiology and Characteristics of Elizabethkingia spp. Infections in Southeast Asia. Microorganisms. 2022; Apr; 10(5):882. doi: 10.3390/microorganisms10050882.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Fraser S. L., Jorgensen J. H. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother. 1997; Dec; 41(12):2738-41. doi: 10.1128/AAC.41.12.2738.</mixed-citation><mixed-citation xml:lang="en">Fraser S. L., Jorgensen J. H. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother. 1997; Dec; 41(12):2738-41. doi: 10.1128/AAC.41.12.2738.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lin P. Y., Chen H. L., Huang C. T. et al. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.Int J Antimicrob Agents. 2010; Nov; 36(5):436-40. doi: 10.1016/j.ijantimicag. 2010.06.033.</mixed-citation><mixed-citation xml:lang="en">Lin P. Y., Chen H. L., Huang C. T. et al. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia.Int J Antimicrob Agents. 2010; Nov; 36(5):436-40. doi: 10.1016/j.ijantimicag. 2010.06.033.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Mirza H. C., Tuncer Ö., Ölmez S. et al. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics. Microb Drug Resist. 2018; Jul/Aug; 24(6): 816-821. doi: 10.1089/mdr.2017.0206.</mixed-citation><mixed-citation xml:lang="en">Mirza H. C., Tuncer Ö., Ölmez S. et al. Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics. Microb Drug Resist. 2018; Jul/Aug; 24(6): 816-821. doi: 10.1089/mdr.2017.0206.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chaponda M., Shaukat A., Dulli M. W. et al. Elizabethkingia meningoseptica Infection in COVID-19 Patients. Cureus. 2022; Oct;14(10): e30337. doi: 10.7759/cureus.30337.</mixed-citation><mixed-citation xml:lang="en">Chaponda M., Shaukat A., Dulli M. W. et al. Elizabethkingia meningoseptica Infection in COVID-19 Patients. Cureus. 2022; Oct;14(10): e30337. doi: 10.7759/cureus.30337.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hashmi A. W., Ahmad M., Israr M. M. et al. Multi-Drug-Resistant Elizabethkingia meningoseptica: A Rare Cause of Late-Onset Sepsis in a Preterm Neonate. Cureus. 2023; Jan;15(1): e34361. doi: 10.7759/cureus.34361.</mixed-citation><mixed-citation xml:lang="en">Hashmi A. W., Ahmad M., Israr M. M. et al. Multi-Drug-Resistant Elizabethkingia meningoseptica: A Rare Cause of Late-Onset Sepsis in a Preterm Neonate. Cureus. 2023; Jan;15(1): e34361. doi: 10.7759/cureus.34361.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
